Recent Articles from GlobeNewswire

Ad hoc announcement pursuant to Art. 53 LR

The following is an update to the fourth quarter 2025 outlook and gives an overview of our current expectations for the fourth quarter. Outlooks presented may vary from the actual fourth quarter 2025 results and are subject to finalisation of those results, which are scheduled to be published on February 5, 2026. Unless otherwise indicated, all outlook statements exclude identified items. 

Freiburg im Breisgau, Germany – January 8, 2026 – Eleva, a pioneer in discovering and developing previously inaccessible biologics, today announced the appointment of Dr. Erich Rajkovic, MBA, as Chief Business Officer. Erich Rajkovic joined Eleva from Affimed, Mannheim/Germany, where he played a key role in originating, negotiating and closing several strategic partnerships with leading pharma and biotechnology companies, as well as academic institutions. At Eleva, he will lead the continued strategic expansion of the company’s pipeline and partnering activities across proprietary programs and external collaborations, supporting the company’s next phase of growth.

Milan, Italy – January 8, 2026 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™/SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, today announced top-line results from a pivotal trial evaluating the REGENERA™ implant in patients undergoing lumpectomy to treat malignant lesions.

Allschwil, Switzerland, January 08, 2026

Leiden, The Netherlands, January 8, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced its preliminary, unaudited revenues for the full year 2025 and plans to host a virtual Investor Day on February 3, 2026, at 10:00 am EST (16:00 CET).

Issy-les-Moulineaux, January 8, 2026 (7am)Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY)

New global customer win underscores authID’s growing leadership in workforce verification and the urgent need for deepfake-resistant identity proofing in hiring

NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Sprouts Farmers Market, Inc. (“Sprouts” or the “Company”) (NasdaqGS: SFM), if they purchased or otherwise acquired the Company’s securities between June 4, 2025 and October 29, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Arizona.

NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 30, 2026 to file lead plaintiff applications in a securities class action lawsuit against DeFi Technologies Inc. (“DeFi” or the “Company”) (NasdaqCM: DEFT), if they purchased or otherwise acquired the Company’s securities between May 12, 2025 and November 14, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.

Leveraging its global regulatory footprint, OwlTing aims to provide merchants the ability to accept payments from the next generation of AI buyers

FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the pricing of an underwritten public offering of 6,875,000 shares of its common stock and pre-funded warrants to purchase 1,250,078 shares of common stock. The shares of common stock are being sold to the public at a price of $16.00 per share and the pre-funded warrants are being sold at a price of $15.999 per pre-funded warrant, which represents the per share price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. The gross proceeds to Phathom from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $130 million. In addition, Phathom has granted the underwriters a 30-day option to purchase up to an additional 1,218,761 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about January 9, 2026, subject to satisfaction of customary closing conditions.

NEW ORLEANS, La., Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company’s securities between October 28, 2024, and October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Washington.

NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (NYSE: ARE), if they purchased or otherwise acquired the Company’s securities between January 27, 2025 to October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.

NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Klarna Group plc (NYSE: KLAR), if they purchased the Company’s securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Klarna’s September 2025 initial public offering (the “IPO”). This action is pending in the United States District Court for the Eastern District of New York.

NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Bitdeer Technologies Group (“Bitdeer” or the "Company") (NasdaqCM: BTDR), if they purchased or otherwise acquired the Company’s securities between June 6, 2024 and November 10, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, La., Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 19, 2026 to file lead plaintiff applications in a securities class action lawsuit against Jayud Global Logistics Limited (“Jayud” or the “Company”) (NasdaqCM: JYD), if they purchased or otherwise acquired the Company’s securities between April 21, 2023 and April 30, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR), if they purchased or otherwise acquired the Company’s shares between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS and LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 12, 2026 to file lead plaintiff applications in a securities class action lawsuit against Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN), if they purchased or otherwise acquired the Company’s securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of Virginia.

NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against Coupang, Inc. (NYSE: CPNG), if they purchased or otherwise acquired the Company’s securities between May 7, 2025 and December 16, 2025, inclusive (the “Class Period”). These actions are pending in the United States District Courts for the Northern District of California and Western District of Washington.

Highlights

Chicago, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The Academy of Nutrition and Dietetics acknowledges the release of the Dietary Guidelines for Americans, 2025–2030 (DGAs). While many recommendations align with longstanding nutrition science, other elements raise concerns that could be detrimental to public health.

MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Jefferson Capital, Inc. (Nasdaq: JCAP) (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today announced the pricing of the underwritten public offering of 10,000,000 shares of common stock by certain of its existing stockholders at a price to the public of $20.50 per share. In addition, the underwriters of the offering have a 30-day option to purchase from the selling stockholders up to 1,500,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The selling stockholders will receive all of the net proceeds from this offering. As part of the secondary offering, Jefferson Capital has agreed to concurrently purchase 3,000,000 shares of its common stock from the underwriters at a per-share purchase price equal to the price payable by the underwriters to the selling stockholders in the offering. The offering and the concurrent share repurchase are expected to close on January 9, 2026, subject to customary closing conditions.

Dallas, TX, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Aqueous Spirits, a U.S.-based importer specializing in premium Hungarian wines, today announced the launch of its national “Celebrating the Wines of Hungary” campaign, a coordinated initiative designed to expand consumer awareness of Hungary’s historic wine regions and strengthen retail engagement across key markets. The program will begin rolling out in late 2025 and continue into 2026, marking the first nationwide educational and in-store activation series in the company’s history.

PASCAGOULA, Miss., Jan. 07, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) hosted John Phelan, secretary of the Navy, along with Adm. Daryl Caudle, chief of naval operations, and Gen. Eric Smith, commandant of the Marine Corps, at its Ingalls Shipbuilding division Wednesday. The senior leaders toured the shipyard, gained insights into HII’s workforce initiatives and discussed Ingalls’ role in delivering the U.S. Navy’s “Golden Fleet” of advanced surface combatants.

New York, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bleichroeder Acquisition Corp. II (the “Company”) announced today the pricing of its initial public offering of 25,000,000 units. The units are expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading tomorrow, January 8, 2026, under the ticker symbol “BBCQU.” Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “BBCQ” and “BBCQW,” respectively. The offering is expected to close on January 9, 2026, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,750,000 units at the initial public offering price to cover over-allotments, if any.

TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX: ILLM) (OTCQB: ILLMF) (“illumin” or the “Company”) today announced that Elliot Muchnik, Chief Financial Officer, is leaving the Company effective immediately to pursue other opportunities.

Investment in Altris, collaboration with InoBat, and roadmap to commercial production of sodium-ion batteries planned before the end of the decade.

Early-stage planning underway across multiple regions, including Louisiana

RED BANK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp. (NASDAQ:OCFC), the holding company for OceanFirst Bank, today announced that it will issue its earnings release for the quarter ended December 31, 2025, on Thursday, January 22, 2026, after the market close. Management will then conduct a conference call at 11:00 a.m. Eastern Time, on Friday, January 23, 2026, to discuss highlights of the Company's quarterly operating performance.

WEST PALM BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Connell Consulting Business Agency, LLC, as Florida lawmakers race toward final action on the Motor Vehicle Insurance (PIP) repeal bill, consumer advocates warn that the legislature is down to just 48 hours to fix a bill that could undo recent progress in lowering auto insurance premiums.

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced the following distribution for the 21shares Ethereum ETF (TETH) for staking rewards earned from its ETH holdings.

SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Klarna Group plc (NYSE: KLAR) securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Klarna's September 10, 2025, initial public offering ("IPO"). Klarna purports to be a “technology-driven payments company, with operations spanning multiple countries.”

SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) --

SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE:FCX) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

Shares Expected to Begin Trading on the NYSE American Exchange on January 8, 2026, under Ticker Symbol “BUDA”

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In F5 (FFIV) To Contact Him Directly To Discuss Their Options

SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a global leader in AI-driven business intelligence for the gaming and hospitality industry, will showcase live demonstrations of its next-generation AI platform at ICE Barcelona 2026, taking place January 19–21 at the Fira Barcelona Gran Via. QCI will appear at a dedicated demo station within the Modulus booth (3X40), highlighting the continued strength of the companies’ strategic collaboration.

Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025

LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2026, to shareholders of record at the close of business on February 28, 2026.

DOWNEY, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company, today announced that on December 31, 2025 certain outstanding indebtedness of the Company, together with accrued interest, totaling approximately $3.05 million, was converted into shares of the Company’s common stock pursuant to a previously executed Debt Conversion Agreement.

VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company”) (NYSE American, TSX: NG) will release its 2025 year-end report before market open on January 22, 2026, followed by a conference call and video webcast to discuss the results at 8:00 am PT (9:00 am MT/11:00 am ET).

DALLAS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, reported financial results for the fiscal second quarter ended November 30, 2025. The Company also provided operational updates.

TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Celestica Inc. (TSX and NYSE: CLS) will release its fourth quarter 2025 financial results after market close on Wednesday, January 28, 2026, and will host a conference call at 8:00am ET on Thursday, January 29, 2026.

MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) (the Company), a leading dental resource organization, announced the completion of two general dentistry practice acquisitions on December 31, 2025: Sunlight Dental in Phoenix, Ariz., and Weddell Dental in Bloomington, Minn. The addition of Sunlight Dental marks Park Dental Partners’ entry into its third state, expands the organization’s geographic reach, and strengthens its commitment to accessible, patient-centered care. Terms of the transactions were not disclosed.

Full lineup to be revealed Thursday, Jan. 8

Michelin expands its Mountain Bike tire product portfolio with two new tire ranges for enduro enthusiasts. The Michelin Wild Enduro and E-Wild Performance Line tires are now available in the U.S. and Canada.

FORT WASHINGTON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE: TOL) (TollBrothers.com), the nation’s leading builder of luxury homes, today announced that, as part of its long-term succession planning process, the Company’s Chairman and Chief Executive Officer Douglas C. Yearley, Jr. will be transitioning to the role of Executive Chairman of the Board on March 30, 2026. The Board of Directors has selected Karl K. Mistry, Executive Vice President and a 22-year Toll Brothers veteran, to succeed Mr. Yearley in the role of Chief Executive Officer and to join the Toll Brothers Board of Directors on March 30, 2026. As Executive Chairman, Mr. Yearley will continue to have a significant management role at the Company including guiding strategic initiatives and supporting the smooth transition of Mr. Mistry into the CEO role.

LOUISVILLE, Ky., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been chosen by Rigel Pharmaceuticals as limited distribution specialty pharmacy partner for TAVALISSE® (fostamatinib disodium hexahydrate), GAVRETO® (pralsetinib), and REZLIDHIA® (olutasidenib).

AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2025. The company anticipates fourth quarter 2025 sales of approximately $823.2 million, an increase of 25.2 percent over the fourth quarter 2024 on an as-reported basis. Full year 2025 sales are expected to be approximately $2.936 billion, an increase of 16.5 percent over the prior year on an as-reported basis.

SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT on Wednesday, January 14, 2026. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fiserv (FISV) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Integer (ITGR) To Contact Him Directly To Discuss Their Options

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sprouts Farmers Market, Inc. (NASDAQ: SFM) and DeFi Technologies Inc. (NASDAQ: DEFT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

STAMFORD, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Grayscale Investments®, the world’s largest digital asset-focused investment platform*, and manager of Grayscale® Decentralized Finance (DeFi) Fund (OTCQB: DEFG) (DeFi Fund), Grayscale® Smart Contract Fund (GSC Fund), and Grayscale® Decentralized AI Fund (AI Fund), today announced the updated Fund Component weightings for each product in connection with their respective fourth quarter 2025 reviews.

ISSAQUAH, Wash., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $29.86 billion for the retail month of December, the five weeks ended January 4, 2026, an increase of 8.5 percent from $27.52 billion last year.

WILMINGTON, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) today announced that it will report its fourth quarter 2025 financial results after U.S. financial markets close on Wednesday, January 21, 2026.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In StubHub (STUB) To Contact Him Directly To Discuss Their Options

Collaborative pilot at Kuji facility showcases robust ethanol yields using LanzaTech’s fermentation technology

New end-to-end system combines opportunity discovery, real-time alerts, proposal drafting, and award-history insights; includes free SAMextension Chrome tool to guide SAM.gov registration

Antwerp, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) has sold eight vessels, generating a capital gain of approximately 269.2 million USD in total.

New York, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company III (Nasdaq: TWLVU) (the “Company”) announced today that, commencing January 9, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and rights included in the units. The Class A ordinary shares and rights that are separated will trade on the Nasdaq Global Market under the symbols “TWLV” and “TWLVR,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “TWLVU.”

Abivax Provides 2026 Corporate Outlook

Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and Expansion

CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026

WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and Chief Financial Officer, will participate in a fireside chat at the CJS Securities 26th Annual New Ideas for the New Year Conference on Wednesday, January 14, 2026 at 8:45 a.m. ET. 

CHARLOTTE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or “the Company”), a developer of small modular nuclear power plants using its Generation IV reactor technology, announced today that it will participate in the 28th Annual Needham Growth Conference on Tuesday, January 13, 2026, in New York, NY.

FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. In addition, Phathom intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of the securities offered in the public offering. There can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering. 

BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 11:15 a.m. PST.

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44thAnnual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific Time.

NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's chief executive officer and president, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT.

FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, Casey Heller, will present at the 28th Annual Needham Growth Conference.

ROCHESTER, N.Y., Jan. 07, 2026 (GLOBE NEWSWIRE) --  Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its third quarter fiscal 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Thursday, January 8, 2026 at 10:30 a.m. ET. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call.